Several
of the Staff have had commercial success spinning
out new companies.
2006 OxTox
2005 Oxford Catalysts Ltd
2005 Oxford Nanolabs
2004 Oxford Medical Diagnostics
2003 ReOx Ltd
2003 VASTox Ltd now Summit plc
2002 Glycoform Ltd
2002 Zyentia Ltd
2002 Pharminox Ltd
2001 Inhibox Ltd
Pre-1998 PowderJect Pharmaceuticals Plc (now Chiron Corporation) (1993); Oxford Asymmetry Int Plc (now Evotec OAI) (1992); Oxford Molecular (now Accelrys Ltd) (1989); MediSense (now Abbott Laboratories) (1984)
Isis Innovation staff help those researchers who wish to commercialise the results of their research. Isis Innovation commercialises intellectual property by licensing, spin-out company formation, consultancy contracts, service contracts and materials sales. ISIS are happy to meet with anyone interested in finding out more about commercialisation and intellectual property. Isis Innovation encourage academic researchers to contact them early with ideas that may have commercial potential. T +44 (0)1865 280830 F +44 (0)1865 280831 E innovation@isis.ox.ac.uk